查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美心肺氧合器市場預測至 2028 年 - 區域分析 - 按產品、應用、類型、年齡層和最終用途
市場調查報告書
商品編碼
1360049

北美心肺氧合器市場預測至 2028 年 - 區域分析 - 按產品、應用、類型、年齡層和最終用途

North America Cardiopulmonary Oxygenator Market Forecast to 2028 -Regional Analysis - By Product, Application, Type, Age Group, and End Use
出版日期: | 出版商: The Insight Partners | 英文 144 Pages | 訂單完成後即時交付

價格

2022年北美心肺氧合器市值為2.6135億美元，預計到2028年將達到3.3451億美元。預計2022年至2028年年複合成長率為4.2%。

隨著人口老化的增加，外科手術的增加正在推動北美心肺氧合器市場的發展

外科手術對於控制心血管疾病和肺部疾病等健康狀況是必要的。在某些醫療情況下，如果不進行手術，就沒有其他選擇。根據美國國家生物技術資訊中心 (NCBI) 2020 年發表的一篇文章，全球每年進行約 3.1 億例大型外科手術，其中 5000-6000 萬例在美國進行。對心血管手術的高需求可歸因於人口老化中心血管疾病發生率的增加。此外，對於患有嚴重肺損傷和未緩解的 COVID-19 相關呼吸衰竭的患者來說，肺移植可能是唯一有用的治療選擇。因此，隨著心血管和肺移植手術數量的不斷增加，該地區對心肺氧合器的需求也不斷增加。

據世界衛生組織稱，預計到 2050 年，60 歲及以上人口的比例將從 2015 年的 12% 增至 22%。心血管疾病仍然是 65 歲以上成年人死亡的主要原因。老化會導致心臟和血管，增加這些疾病的風險。因此，老年族群心血管疾病的盛行率促進了心肺氧合器市場的成長。

北美心肺氧合器市場概況

北美的心肺氧合器市場分為美國、加拿大和墨西哥。預計美國將成為該地區市場的最大貢獻者。北美市場的成長歸因於該地區心血管和呼吸系統疾病盛行率的上升。這增加了慢性阻塞性肺病、慢性支氣管炎、充血性心臟衰竭等心肺疾病的發生率。例如，根據美國肺臟協會的數據，2020 年，美國約有1,250 萬人被診斷出患有慢性阻塞性肺病、慢性支氣管炎和肺氣腫。此外，此類疾病的盛行率和發生率不斷上升，導致大量患者群體中接受外科手術的數量增加推動了心肺氧合器市場的成長。例如，根據壽命健康系統發表的研究，美國每年進行約 50 萬例心臟直視手術。此外，呼吸衰竭和傳染病患者病率的增加預計將進一步創造對心肺氧合器的需求。

此外，心血管疾病盛行率的上升是全球死亡的主要原因，而氧合器可以在緊急情況下為挽救生命提供巨大幫助。根據世界衛生組織的數據，每年約有 1,790 萬人因心血管疾病而喪生。此外，優惠的報銷政策也有望為心肺氧合器的發展創造充足的機會。因此，心肺疾病盛行率和發病率的上升預計將在預測期內推動心肺氧合器市場的成長。

北美心肺氧合器市場收入及2028年預測（百萬美元）

北美心肺氧合器市場細分

北美心肺氧合器市場分為產品、應用、類型、年齡層、最終用途和國家。根據產品，市場分為膜式氧合器和氣泡式氧合器。 2022年，膜式氧合器細分市場將佔據更大的市場。

根據應用，市場分為心臟和呼吸系統。到2022年，心臟細分市場將佔據更大的市場佔有率。此外，心臟細分為急性心肌梗塞、心肌炎、移植後併發症、失代償性心肌病變等。此外，呼吸系統又分為呼吸衰竭、急性呼吸窘迫症候群、肺栓塞、肺炎和 COVID-19。

根據類型，市場分為可重複使用心肺氧合器和拋棄式心肺氧合器。 2022 年，可重複使用心肺氧合器細分市場將佔據更大的市場佔有率。

根據年齡層，市場分為成人、兒童和新生兒。 2022 年，成人細分市場佔據最大的市場佔有率。

根據最終用途，市場分為醫院和診所、門診手術中心等。 2022 年，醫院和診所細分市場佔據最大市場佔有率。

根據國家/地區，市場分為美國、加拿大和墨西哥。 2022 年，美國佔據市場佔有率主導地位。

潔定公司；利瓦諾瓦有限公司；美敦力公司；泰爾茂公司；尼普羅醫療公司；微創科學公司；點字生物醫學工業、商業和代表有限公司；聖杯醫療有限公司；和 Fresenius Medical Care AG & Co KGaA 是該地區心肺氧合器市場的領先公司。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 北美心肺氧合器市場 - 按產品
    • 北美心肺氧合器市場 - 按應用
    • 北美心肺氧合器市場 - 按類型
    • 北美心肺氧合器市場 - 按年齡段
    • 北美心肺氧合器市場 - 按最終用途
    • 北美心肺氧合器市場 - 按國家/地區

第 2 章：北美心肺氧合器市場要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美心肺氧合器市場 - 市場格局

  • 概述
  • PEST分析
    • 北美 PEST 分析

專家意見

第 5 章：北美心肺氧合器市場 - 主要市場動態

  • 市場促進因素
    • 心肺疾病發生率上升
    • 隨著人口老化的激增，外科手術數量不斷增加
  • 市場限制
    • 缺乏熟練的專業人員
  • 市場機會
    • 增加兒科和新生兒患者心肺氧合器的使用
  • 未來的趨勢
    • 攜帶式體外膜氧合在肺移植手術的應用
  • 影響分析

第 6 章：心肺氧合器市場 - 北美分析

  • 北美心肺氧合器市場收入預測與分析

第 7 章：北美心肺氧合器市場 - 收入和 2028 年預測 - 按產品

  • 概述
  • 2021 年及 2028 年心肺氧合器市場收入佔有率（按產品分類）
  • 薄膜充氧器
  • 氣泡充氧器

第 8 章：北美心肺氧合器市場 - 收入和 2028 年預測 -按應用

  • 概述
  • 心肺氧合器市場收入佔有率，按類型 2021 年和 2028 年 (%)
  • 心臟
  • 呼吸系統

第 9 章：2028 年北美心肺氧合器市場分析與預測 - 按類型

  • 概述
  • 心肺氧合器市場，按類型 2021 年和 2028 年 (%)
  • 可重複使用的製氧器
  • 免洗機

第 10 章：2028 年北美心肺氧合器市場分析與預測 - 按年齡層

  • 概述
  • 心肺氧合器市場，依年齡層 2021 年和 2028 年 (%)
  • 成年人
  • 兒科
  • 新生兒

第 11 章：北美心肺氧合器市場 - 收入和 2028 年預測 - 按最終用途

  • 概述
  • 心肺氧合器市場收入佔有率，以最終用途 2021 年和 2028 年 (%)
  • 醫院和診所
  • 門診手術中心
  • 其他

第 12 章：北美心肺氧合器市場 - 收入和 2028 年預測 - 按國家分析

  • 北美洲

第 13 章：北美心肺氧合器市場-產業格局

  • 概述
  • 心肺氧合器市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 14 章：公司簡介

  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • Terumo Corp
  • Nipro Medical Corp
  • MicroPort Scientific Corp
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Chalice Medical Ltd
  • Fresenius Medical Care AG & Co KGaA

第 15 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: BMIRE00028632

The North America Cardiopulmonary Oxygenator Market was valued at US$ 261.35 million in 2022 and is expected to reach US$ 334.51 million by 2028. It is estimated to register a CAGR of 4.2% from 2022 to 2028.

Increasing Surgical Procedures with Surging in Aging Population is Fueling North America Cardiopulmonary Oxygenator Market

Surgical procedures are necessary for managing health conditions such as cardiovascular diseases and lung disorders. In some medical cases, no alternative works without surgery. Per an article published in the National Center for Biotechnology Information (NCBI) in 2020, ~310 million major surgical operations are carried out each year worldwide, of which 50-60 million are performed in the US. The high demand for cardiovascular surgeries can be attributed to the increase in the incidence of cardiovascular diseases in the aging population. Further, lung transplantation may be the only helpful treatment option for patients experiencing serious lung damage and non-resolving COVID-19-associated respiratory failure. Thus, with the growing number of cardiovascular and lung transplant surgeries, the demand for cardiopulmonary oxygenators is also on the rise in the region.

According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Cardiovascular diseases continue to be the leading cause of death among adults over the age of 65. Aging can cause changes in the heart and blood vessels, increasing the risk of developing these diseases. Therefore, the prevalence of cardiovascular diseases among geriatric populations is contributing to the growth of the cardiopulmonary oxygenators market.

North America Cardiopulmonary Oxygenator Market Overview

The cardiopulmonary oxygenators market in North America is segmented into the US, Canada, and Mexico. The US is expected to be the largest contributor to the market in this region. The market growth in North America is ascribed to the rising prevalence of cardiovascular and respiratory disorders in the region. This has increased the incidence of cardiopulmonary disorders such as COPD, chronic bronchitis, congestive heart failure, and others. For instance, as per American Lung Association, ~12.5 million people are diagnosed with COPD, chronic bronchitis, and emphysema in the US in 2020. Moreover, rising prevalence and incidences of such disorders have increased the number of surgical procedures among large patient population which has fueled the growth of cardiopulmonary oxygenator market. For instance, as per study published by lifespan health system, ~500,00 open heart surgeries are performed in the US every year. Additionally, increase in prevalence of respiratory failure and infectious diseases are further expected to create demand for cardiopulmonary oxygenator.

Furthermore, rising prevalence of cardiovascular disorders are the leading cause of death on the global level and oxygenator can be of great assistance in lifesaving in emergency cases. As per world health organization, ~17.9 million lives are lost due to CVDs annually. Moreover, favorable reimbursement policies are also expected to create ample opportunities for the growth of cardiopulmonary oxygenator. Therefore, rising prevalence and incidence of cardiopulmonary disorders are expected to drive the growth of cardiopulmonary oxygenator market during the forecast period.

North America Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)

North America Cardiopulmonary Oxygenator Market Segmentation

The North America Cardiopulmonary Oxygenator Market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.

Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.

Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.

Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.

Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.

Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.

Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Nipro Medical Corp; Microport Scientific Corp; Braile Biomedica Industry, Commerce and Representation Ltd; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the Cardiopulmonary Oxygenator Market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Cardiopulmonary Oxygenator market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in North America Cardiopulmonary Oxygenator market, thereby allowing players across the value chain to develop effective long-term strategies
  • develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Cardiopulmonary Oxygenator market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Cardiopulmonary Oxygenator Market - by Product
    • 1.3.2 North America Cardiopulmonary Oxygenator Market - by Application
    • 1.3.3 North America Cardiopulmonary Oxygenator Market - by Type
    • 1.3.4 North America Cardiopulmonary Oxygenator Market - by Age Group
    • 1.3.5 North America Cardiopulmonary Oxygenator Market - by End Use
    • 1.3.6 North America Cardiopulmonary Oxygenator Market - by Country

2. North America Cardiopulmonary Oxygenator Market Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Cardiopulmonary Oxygenator Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis

Expert's Opinion

5. North America Cardiopulmonary Oxygenators Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Incidence of Cardiopulmonary Diseases
    • 5.1.2 Increasing Surgical Procedures with Surging in Aging Population
  • 5.2 Market Restraints
    • 5.2.1 Lack of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Usage of Cardiopulmonary Oxygenators in Pediatric and Neonatal Patients
  • 5.4 Future Trends
    • 5.4.1 Use of Portable Extracorporeal Membrane Oxygenation in Lung Transplant Procedures
  • 5.5 Impact Analysis

6. Cardiopulmonary Oxygenators Market - North America Analysis

  • 6.1 North America Cardiopulmonary Oxygenators Market Revenue Forecast and Analysis

7. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Product

  • 7.1 Overview
  • 7.2 Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
  • 7.3 Membrane Oxygenator
    • 7.3.1 Overview
    • 7.3.2 Membrane Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Bubble Oxygenator
    • 7.4.1 Overview
    • 7.4.2 Bubble Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Application

  • 8.1 Overview
  • 8.2 Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
  • 8.3 Cardiac
    • 8.3.1 Overview
    • 8.3.2 Cardiac: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.3 Acute myocardial infarction
    • 8.3.4 Overview
    • 8.3.5 Acute myocardial infarction: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.6 Myocarditis
    • 8.3.7 Overview
    • 8.3.8 Myocarditis: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.9 Post-transplant complication
    • 8.3.10 Overview
    • 8.3.11 Post-transplant complication: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.12 Decompensated Cardiomyopathy
    • 8.3.13 Overview
    • 8.3.14 Decompensated Cardiomyopathy: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.15 Others
    • 8.3.16 Overview
    • 8.3.17 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Respiratory
    • 8.4.1 Overview
    • 8.4.2 Respiratory: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Respiratory Failure
    • 8.4.4 Overview
    • 8.4.5 Respiratory Failure: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Acute Respiratory Distress Syndrome
    • 8.4.7 Overview
    • 8.4.8 Acute Respiratory Distress Syndrome: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.9 Pulmonary Embolism
    • 8.4.10 Overview
    • 8.4.11 Pulmonary Embolism: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.12 Pneumonia
    • 8.4.13 Overview
    • 8.4.14 Pneumonia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.15 COVID-19
    • 8.4.16 Overview
    • 8.4.17 COVID-19: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Type

  • 9.1 Overview
  • 9.2 Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
  • 9.3 Reusable Oxygenator
    • 9.3.1 Overview
    • 9.3.2 Reusable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Disposable Oxygenator
    • 9.4.1 Overview
    • 9.4.2 Disposable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Age Group

  • 10.1 Overview
  • 10.2 Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
  • 10.3 Adults
    • 10.3.1 Overview
    • 10.3.2 Adults: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Pediatric
    • 10.4.1 Overview
    • 10.4.2 Pediatric: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Neonates
    • 10.5.1 Overview
    • 10.5.2 Neonates: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by End Use

  • 11.1 Overview
  • 11.2 Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
  • 11.3 Hospitals and Clinics
    • 11.3.1 Overview
    • 11.3.2 Hospitals and Clinics: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Ambulatory Surgical Centers
    • 11.4.1 Overview
    • 11.4.2 Ambulatory Surgical Centers: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

12. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Country Analysis

  • 12.1 North America: Cardiopulmonary Oxygenators Market
    • 12.1.1 Overview
    • 12.1.3 North America: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
      • 12.1.3.1 United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.1.1 Overview
        • 12.1.3.1.2 United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.1.3 United States: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
        • 12.1.3.1.4 United States: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
        • 12.1.3.1.4.1 United States: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
        • 12.1.3.1.4.2 United States: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
        • 12.1.3.1.5 United States: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
        • 12.1.3.1.6 United States: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
        • 12.1.3.1.7 United States: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
      • 12.1.3.2 Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.2.1 Overview
        • 12.1.3.2.2 Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.2.3 Canada: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
        • 12.1.3.2.4 Canada: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
        • 12.1.3.2.4.1 Canada: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
        • 12.1.3.2.4.2 Canada: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
        • 12.1.3.2.5 Canada: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
        • 12.1.3.2.6 Canada: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
        • 12.1.3.2.7 Canada: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
      • 12.1.3.3 Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.3.1 Overview
        • 12.1.3.3.2 Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.3.3 Mexico: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
        • 12.1.3.3.4 Mexico: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
        • 12.1.3.3.4.1 Mexico: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
        • 12.1.3.3.4.2 Mexico: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
        • 12.1.3.3.5 Mexico: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
        • 12.1.3.3.6 Mexico: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
        • 12.1.3.3.7 Mexico: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)

13. North America Cardiopulmonary Oxygenators Market-Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Cardiopulmonary Oxygenator Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Getinge AB
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 LivaNova Plc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Medtronic Plc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Terumo Corp
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Nipro Medical Corp
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 MicroPort Scientific Corp
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Braile Biomedica Industry, Commerce and Representations Ltd
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
  • 14.8 Chalice Medical Ltd
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Fresenius Medical Care AG & Co KGaA
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. United States Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 2. United States Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
  • Table 3. United States Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
  • Table 4. United States Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
  • Table 5. United States Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
  • Table 6. United States Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
  • Table 7. United States Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
  • Table 8. Canada Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 9. Canada Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
  • Table 10. Canada Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
  • Table 11. Canada Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
  • Table 12. Canada Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
  • Table 13. Canada Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
  • Table 14. Canada Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
  • Table 15. Mexico Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 16. Mexico Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
  • Table 17. Mexico Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
  • Table 18. Mexico Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
  • Table 19. Mexico Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
  • Table 20. Mexico Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
  • Table 21. Mexico Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
  • Table 22. Recent Organic Growth Strategies in North America Cardiopulmonary Oxygenator Market
  • Table 23. Recent Inorganic Growth Strategies in The North America Cardiopulmonary Oxygenator Market
  • Table 24. Glossary of Terms

List Of Figures

  • Figure 1. North America Cardiopulmonary Oxygenator Market Segmentation
  • Figure 2. North America Cardiopulmonary Oxygenator Market, by Country
  • Figure 3. North America Cardiopulmonary Oxygenator Market Overview
  • Figure 4. Membrane Oxygenator Segment Held Largest Share of Product Segment in Cardiopulmonary Oxygenator Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. North America Experts\' Opinion
  • Figure 8. North America Cardiopulmonary Oxygenators Market: Impact Analysis of Drivers and Restraints
  • Figure 9. North America Cardiopulmonary Oxygenators Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
  • Figure 11. Membrane Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Bubble Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. North America Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
  • Figure 14. Cardiac: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Acute myocardial infarction: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Myocarditis: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Post-transplant Complication: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Decompensated Cardiomyopathy: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Others: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Respiratory: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Respiratory Failure: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Acute Respiratory Distress Syndrome: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Pulmonary Embolism: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Pneumonia: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. COVID-19: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. North America Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
  • Figure 27. Reusable Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Disposable Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. North America Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
  • Figure 30. Adults: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Pediatric: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Neonates: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. North America Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
  • Figure 34. Hospitals and Clinics: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Ambulatory Surgical Centers: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Others: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. North America: Cardiopulmonary Oxygenators Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 38. North America: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
  • Figure 39. United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
  • Figure 40. Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
  • Figure 41. Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
  • Figure 42. North America Growth Strategies in Cardiopulmonary Oxygenator Market